Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 2, 2022

View Archived Issues

New murine model of AIH developed using a human liver protein

Science & Technology Development Fund Authority presents new antiviral nucleosides

New DDR1 and/or DDR2 inhibitors identified at Galapagos

PI3K-delta inhibitors patented by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical

Sichuan Haisco Pharmaceutical discovers polymerase basic protein 2 inhibitors

Beijing Findcure Biosciences divulges new tyrosine-protein kinase receptor UFO inhibitors

SLAMF3 and SLAMF4 targeting for treating hematopoietic cancers

HMGB1 restricts EPO signaling, contributing to anemia of inflammation

CCR4 mediates postoperative pain through skin dendritic cells

Sarepta and GenEdit report progress under collaboration for neuromuscular diseases

Catalog of protein isoforms in blood cells can predict organ rejection

Skye reports data on SBI-100 ophthalmic nanoemulsion in preclinical glaucoma model

Neuronal PFKFB3 upregulation involved in ceroid lipofuscinosis

Discovery of novel ATX inhibitor with promising antifibrosis efficacy in rodents